Search
Selected: All

N-Acylpeptide compound, processes for the preparation thereof an

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-carbamylated orgotein

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-Carboxyalkylproline-containing tripeptides

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-Substituted cyclopeptide derivatives

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-Substituted dimeric cyclopeptide derivatives

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-substituted dimeric cyclopeptide derivatives and preparation t

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-Terminal substituted oligopeptide converting enzyme inhibitors

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -Alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharm

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -alkoxynaphthylsulfonyl-L-argininamides and the pharmace

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -arylsulfonyl-argininamides and the pharmaceutically acc

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -arylsulfonyl-l-argininamides and the pharmaceutically a

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically a

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically a

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically a

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.